Business Wire

Manhattan Genomics Unveils World-Class Scientific Team to Pioneer New Era of Genomic Medicine and Eradicate Inherited Disease

Company taps John R. Quain, Norbert Gleicher, MD, Carol Hanna, Ph.D, Jon Hennebold, Ph.D, and Stephen Turner, Ph.D to its world-class team to advance responsible genomic medicine. NEW YORK--(BUSINESS ...
La Grande Observer

Circular Genomics Joins Lilly Gateway Labs in San Diego to Develop Its Best-In-Class Circular RNA Platform for the Diagnosis and Prognosis of Alzheimer’s Disease

Circular Genomics’ move to the Lilly Gateway Labs community will enhance scientific collaboration and innovation to foster the development of its Alzheimer’s disease diagnostic and prognostic blood ...
The Cornell Daily Sun

What’s in Your DNA? Cornell Genomics Class Provides Students Free 23andMe Testing

The first-ever sequencing of the human genome cost $2.7 billion. Today, the service 23andMe offers personal genome sequencing for less than $200. And for students enrolled in Cornell’s personal ...
Morningstar

Circular Genomics to Unveil New Data Highlighting Circular RNAs as a Transformative New Class of Blood-Based Biomarkers for Alzheimer's Disease at CTAD 2025

New clinical data highlights circular RNAs (circRNAs) as a novel, non-invasive blood biomarker platform for the early detection of Alzheimer's Disease (AD). The research demonstrates that circRNAs ...